Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Single-dose pharmacokinetic interaction between artesunate and amodiaquine: assembling the clues for the purported interaction.

× No keyword cloud information.

16 in total

1. Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers.

Authors: Timothy M E Davis; Michelle England; Anne-Marie Dunlop; Madhu Page-Sharp; Nathalie Cambon; Thomas G Keller; János L Heidecker; Kenneth F Ilett
Journal: Antimicrob Agents Chemother Date: 2006-12-18 Impact factor: 5.191

2. Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.

Authors: Xue-Qing Li; Anders Björkman; Tommy B Andersson; Marianne Ridderström; Collen M Masimirembwa
Journal: J Pharmacol Exp Ther Date: 2002-02 Impact factor: 4.030

3. Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers.

Authors: S Q Zhang; T N Hai; K F Ilett; D X Huong; T M Davis; M Ashton
Journal: Br J Clin Pharmacol Date: 2001-10 Impact factor: 4.335

4. Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.

Authors: O M S Minzi; A Gupta; A F Haule; G A B Kagashe; A Y Massele; L L Gustafsson
Journal: Eur J Clin Pharmacol Date: 2007-02-27 Impact factor: 2.953

5. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.

Authors: Naeem Durrani; Toby Leslie; Sayed Rahim; Kate Graham; Fayaz Ahmad; Mark Rowland
Journal: Trop Med Int Health Date: 2005-06 Impact factor: 2.622

6. Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.

Authors: S Parikh; J-B Ouedraogo; J A Goldstein; P J Rosenthal; D L Kroetz
Journal: Clin Pharmacol Ther Date: 2007-03-14 Impact factor: 6.875

7. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.

Authors: Xue-Qing Li; Anders Björkman; Tommy B Andersson; Lars L Gustafsson; Collen M Masimirembwa
Journal: Eur J Clin Pharmacol Date: 2003-08-12 Impact factor: 2.953

8. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.

Authors: Sara Asimus; Doaa Elsherbiny; Trinh N Hai; Britt Jansson; Nguyen V Huong; Max G Petzold; Ulrika S H Simonsson; Michael Ashton
Journal: Fundam Clin Pharmacol Date: 2007-06 Impact factor: 2.748

9. Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers.

Authors: Sharon I Omoruyi; Cyprian O Onyeji; Michael O Daniyan
Journal: Ther Drug Monit Date: 2007-04 Impact factor: 3.681

10. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.

Authors: Catherine Orrell; Francesca Little; Peter Smith; Peter Folb; Walter Taylor; Piero Olliaro; Karen I Barnes
Journal: Eur J Clin Pharmacol Date: 2008-04-16 Impact factor: 2.953

1 in total

1. Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.

Authors: Joel Tarning; Palang Chotsiri; Vincent Jullien; Marcus J Rijken; Martin Bergstrand; Mireille Cammas; Rose McGready; Pratap Singhasivanon; Nicholas P J Day; Nicholas J White; Francois Nosten; Niklas Lindegardh
Journal: Antimicrob Agents Chemother Date: 2012-08-27 Impact factor: 5.191

1 in total